Dentists in Preston, MN Accepting Medicare
2 Dentists found. Showing 1 - 2
 Richard Craft Cohen, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 317 Saint Paul St Sw, Preston, MN 55965 Phone: 507-765-3634 |
 Tami Karban Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 317 Saint Paul St Sw, Preston, MN 55965 Phone: 507-765-3634 |
News Archive
Tips for treating loose tooth
Pulling a tooth is a rite of passage for children as they shed their baby teeth for an adult set. But parents often ask: What are the safest and most painless ways to pull a loose tooth?
DataSource partners with Rural Health to help customers secure grants for EHR projects
DataSource Mobility is committed to helping healthcare customers achieve their IT goals. As part of that commitment, they have extended their capabilities by partnering with Rural Health IT Corporation (Rural Health), to provide customers with assistance in securing grant funding for EHR projects up to $1.2 million.
Commonwealth Employment Relations Board rules that Cambridge Health Alliance violated state labor law
The Commonwealth Employment Relations Board (CERB) ruled today that Cambridge Health Alliance (CHA) violated state labor law, by bargaining in bad faith and depriving nurses of their union rights following CHA's decision to prematurely cease negotiations, declare impasse and unilaterally slash nurses' retiree health benefit.
GE Healthcare and Intel expand sales and marketing agreement for Intel Health Guide in the U.K.
GE Healthcare, a unit of GE, and Intel Corporation (NASDAQ:INTC) announced today that they have expanded their sales and marketing agreement for the Intel Health Guide to include the United Kingdom. GE Healthcare already markets the Intel Health Guide in the United States.
TCD announces first patient treated in its TCD-717 Phase I trial
Traslational Cancer Drugs Pharma, S.L. ("TCD") announced today that the first patient was treated on Friday the 18th of February with TCD-717 in a Phase I study performed in patients with advanced solid tumors. TCD-717 is a first-in-class, small molecule that precisely inhibits Choline Kinase Alpha, an enzyme heavily involved in the carcinogenic process. A total of 30 patients are planned to be treated in the trial, which will be conducted in accordance with FDA approval, in two leading medical centers in the U.S. The
› Verified 2 days ago